文献评审日期：2025-08-22

1. CatapanoAL, ReinerZ, De BackerG, et al. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) [J]. Atherosclerosis, 2011, 217(1):3-46.2. 中华医学会外科学分会血管外科学组. 下肢动脉硬化闭塞症诊治指南[J]. 中华医学杂志,2015,95(24)：1883-1896. DOI:10.3760/cma.j.issn.0376-2491.2015.24.0043. RubinsHB, RobinsSJ, CollinsD, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group[J]. N Engl J Med, 1999, 341(6):410-418.展开